VivoSeq
Other

Sevoflurane

0

Pipeline Programs

5

Active Trials

1

Companies Involved

Sevoflurane is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

75

clinical trials

Completed54 · 72%
Unknown status12 · 16%
Terminated3 · 4%
Not yet recruiting2 · 3%
Recruiting2 · 3%
Active, not recruiting1 · 1%
Other1 · 1%

Trial Activity

75 trials

Blood Levels of Sevoflurane and Desflurane
Completed··N/A·NCT03015350·16 enrolled
Desflurane vs. Sevoflurane in Endovascular Aortic Repair
Completed··Phase 4·NCT03917186·80 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)